Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Prepaid Assets: 2011-2024

Historic Prepaid Assets for Niagen Bioscience (NAGE) over the last 11 years, with Dec 2024 value amounting to $2.5 million.

  • Niagen Bioscience's Prepaid Assets fell 3.20% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 million, marking a year-over-year decrease of 3.20%. This contributed to the annual value of $2.5 million for FY2024, which is 1.31% up from last year.
  • Per Niagen Bioscience's latest filing, its Prepaid Assets stood at $2.5 million for FY2024, which was up 1.31% from $2.5 million recorded in FY2023.
  • Niagen Bioscience's 5-year Prepaid Assets high stood at $3.0 million for FY2022, and its period low was $1.1 million during FY2020.
  • Moreover, its 3-year median value for Prepaid Assets was $2.5 million (2024), whereas its average is $2.6 million.
  • Its Prepaid Assets has fluctuated over the past 5 years, first soared by 62.36% in 2021, then decreased by 17.43% in 2023.
  • Niagen Bioscience's Prepaid Assets (Yearly) stood at $1.1 million in 2020, then skyrocketed by 62.36% to $1.9 million in 2021, then spiked by 59.60% to $3.0 million in 2022, then fell by 17.43% to $2.5 million in 2023, then rose by 1.31% to $2.5 million in 2024.